Comparison of SP142 and 22C3 PD-L1 Assays in a Population-Based Cohort of Triple-Negative Breast Cancer Patients in the Context of Their Clinically Established Scoring Algorithms.
BREAST CANCER RESEARCH（2023）
关键词
Triple-negative breast cancer,PD-L1,Immunohistochemistry,SP142,22C3,Concordance,TILs,Patient outcome,Gene expression
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要